Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: The DLC-1 tumor suppressor is involved in regulating immunomodulation of human mesenchymal stromal /stem cells through interacting with the Notch1 protein

Fig. 1

The treatment with GSI-I elevates DLC-1 protein level in hUC-MSCs through proteasome inhibition. Western blotting showed a dose-dependent increase in protein expression for DLC-1 at 24 h after GSI-I treatment (a), while the immunoprecipitation from the cell lysates using the antibodies against DLC-1 showed an increase in the polyubiquinated form of DLC-1 protein (b)

Back to article page
\